FDA Approved: TIGECYCLINE — Supplemental Application (Apotex Corp)

View source ↗

Summary

FDA approved a supplemental application for tigecycline from Apotex Corp, indicating an approved addition or update under the supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Intra-abdominal Infections
• Complicated Skin and Soft Tissue Infections

Drugs mentioned

• Tigecycline (tigecycline)

Snippet

SUPPL AP for TIGECYCLINE (TIGECYCLINE)